Insider · CIK 0001453356
10X Fund, L.P.
Files at GALT (GALECTIN THERAPEUTICS INC). First filing Oct 24, 2025, latest Dec 18, 2025.
10X Fund, L.P. files SEC Form 4 as 10% owner at GALT (GALECTIN THERAPEUTICS INC). Since Oct 24, 2025, 10X Fund, L.P. has reported 0 open-market buys worth $0 and 5 open-market sells worth $2.4M, the latest filed on Dec 18, 2025.
A track record needs three past buys with six months of prices behind them; 10X Fund, L.P. has 0, so none is measured yet.
The newest scored trade: sold $204k of GALT on Dec 16, 2025, filed Dec 18, 2025, scored 39 (weak). In the last 12 months: 0 buys worth $0 and 5 sells worth $2.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GALT: GALECTIN THERAPEUTICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | GALECTIN THERAPEUTICS INC | $204k 30,681 shares | -1% | +638% from low-5% from high | |
| 44Moderate | GALECTIN THERAPEUTICS INC | $921k 162,069 shares | -3% | +550% from low-12% from high | |
| 43Moderate | GALECTIN THERAPEUTICS INC | $852k 150,000 shares | -3% | +550% from low-12% from high | |
| 39Weak | GALECTIN THERAPEUTICS INC | $210k 40,000 shares | -1% | +555% from low-8% from high | |
| 40Moderate | GALECTIN THERAPEUTICS INC | $247k 50,000 shares | -1% | +481% from low-18% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | GALT GALECTIN THERAPEUTICS INC | JOther Common Stock | -24,000 | - | - | 5,645,138 | Dec 18, 2025 |
| Dec 16, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -30,681 | $6.66 | $204k | 5,614,457 | Dec 18, 2025 |
| Dec 2, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -30,000 | $5.47 | $164k | 5,802,207 | Dec 8, 2025 |
| Dec 3, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -132,069 | $5.73 | $757k | 5,670,138 | Dec 8, 2025 |
| Dec 2, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -30,000 | $5.47 | $164k | 5,802,207 | Dec 4, 2025 |
| Dec 3, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -120,000 | $5.73 | $688k | 5,682,207 | Dec 4, 2025 |
| Nov 11, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -40,000 | $5.25 | $210k | 5,832,207 | Nov 12, 2025 |
| Oct 22, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -20,000 | $4.93 | $99k | 5,902,207 | Oct 24, 2025 |
| Oct 22, 2025 | GALT GALECTIN THERAPEUTICS INC | SOpen-market sale Common Stock | -30,000 | $4.94 | $148k | 5,872,207 | Oct 24, 2025 |
Questions about 10X Fund, L.P.
Answered from the filings on this page, as of the latest one.
Is 10X Fund, L.P. buying or selling?
In the last 12 months 10X Fund, L.P. reported 0 open-market buys worth $0 and 5 open-market sells worth $2.4M on SEC Form 4; the latest was sold $204k of GALT on Dec 16, 2025. Grants, option exercises and tax withholding are not counted.
How did 10X Fund, L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and 10X Fund, L.P. has 0.
Where does 10X Fund, L.P. file Form 4?
10X Fund, L.P. has filed Form 4 at GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.